Overview

Malaria High-Risk Populations in Namibia

Status:
Completed
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
This study aims to determine the effectiveness, cost-effectiveness, acceptability, and feasibility of targeted delivery of a package of malaria interventions for improving effective coverage and reducing Plasmodium falciparum malaria transmission among malaria high-risk populations in Northern Namibia. Previous research identified cattle herders and agricultural workers as populations at higher risk of infection. The investigators hypothesize that targeted delivery of interventions will lead improve coverage in these groups and lead to a reduction in P. falciparum transmission.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
London School of Hygiene and Tropical Medicine
Ministry of Health and Social Services, Namibia
University of Namibia
University of Notre Dame
University of Texas Southwestern Medical Center
Treatments:
Artemether
Artemether, Lumefantrine Drug Combination
Lumefantrine